Table 3

Summary data for individual tests

Anatomical findingStudies (imaging modality)Sensitivity (95% CI), %Specificity (95% CI), %Positive likelihood ratio (95% CI)Negative likelihood ratio (95% CI)
Cervical interspinous bursitisSalvarani et al36 (MRI)0.83 (0.55 to 0.95)0.69 (0.42 to 0.87)2.7 (1.2 to 6.4)0.24 (0.065 to 0.90)
Cervical interspinous bursitis, comparator no inflammationCamellino et al25 (PET/CT)0.10 (0.05 to 0.19)0.99 (0.93 to 1.00)13 (0.8 to 226)0.9 (0.91 to 0.99)
Lumbar interspinous bursitisSalvarani et al37 (MRI)0.60 (0.31 to 0.83)0.91 (0.62 to 0.98)6.6 (1.0 to 46)0.4 (0.20 to 0.96)
Lumbar interspinous bursitis, comparator no inflammationCamellino et al25 (PET/CT)0.46 (0.35 to 0.48)0.99 (0.93 to 1.00)61 (3.8 to 977)0.54 (0.43 to 0.68)
Any interspinous bursitisYamashita et al35 (PET/CT)0.79 (0.52 to 0.92)0.82 (0.59 to 0.94)4.5 (1.5 to 13)0.26 (0.093 to 0.73)
Subacromial bursitis on at least one sideCantini et al33 (USS)0.96 (0.88 to 0.99)0.78 (0.70 to 0.85)4.4 (3.1 to 6.2)0.04 (0.01 to 0.18)
Frediani et al45 (USS)0.70 (0.56 to 0.81)0.61 (0.51 to 0.70)1.8 (1.3 to 2.4)0.49 (0.31 to 0.77)
Falsetti et al44 (USS)0.79 (0.62 to 0.90)0.59 (0.42 to 0.74)2.0 (1.2 to 3.1)0.35 (0.16 to 0.75)
Dasgupta et al15 (USS)0.56 (0.47 to 0.65)0.65 (0.58 to 0.72)1.6 (1.2 to 2.1)0.67 (0.53 to 0.85)
Cantini et al33 (USS)*
Frediani et al45 (USS)
Falsetti et al44 (USS)
Dasgupta et al15 (USS)
0.80 (0.55 to 0.93)0.68 (0.60 to 0.75)2.5 (1.6 to 3.8)0.30 (0.11 to 0.81)
Subacromial bursitis on at least one side: comparator RASalvarani et al48 (MRI)0.96 (0.73 to 1.00)0.75 (0.44 to 0.92)3.86 (1.3 to 11)0.05 (0.003 to 0.74)
Coari et al38 (USS)0.09 (0.03 to 0.24)0.90 (0.84 to 0.94)0.95 (0.29 to 3.2)1.01 (0.89 to 1.1)
Dasgupta et al15 (USS)0.56 (0.47 to 0.65)0.72 (0.57 to 0.83)2.0 (1.2 to 3.2)0.61 (0.46 to 0.80)
Ruta et al39 (USS)0.73 (0.56 to 0.86)0.67 (0.49 to 0.81)2.2 (1.3 to 3.8)0.40 (0.21 to 0.76)
Subacromial bursitis on at least one side: comparator painful shoulder conditionsDasgupta et al15 (USS)0.56 (0.47 to 0.65)0.70 (0.55 to 0.81)1.9 (1.2 to 2.9)0.63 (0.48 to 0.83)
Ruta et al39 (USS)0.55 (0.43 to 0.67)0.75 (0.63 to 0.84)2.2 (1.3 to 3.6)0.60 (0.44 to 0.82)
Subacromial bursitis on both sidesCantini et al33 (USS)0.93 (0.83 to 0.97)0.99 (0.95 to 1.00)106 (15 to 747)0.07 (0.028 to 0.18)
Frediani et al45 (USS)0.54 (0.40 to 0.67)0.68 (0.58 to 0.76)1.7 (1.1 to 2.5)0.68 (0.49 to 0.94)
Falsetti et al44 (USS)0.69 (0.51 to 0.83)0.78 (0.61 to 0.89)3.2 (1.6 to 6.3)0.40 (0.22 to 0.70)
Dasgupta et al15 (USS)0.32 (0.24 to 0.41)0.88 (0.81 to 0.92)2.6 (1.6 to 4.2)0.78 (0.68 to 0.89)
Cantini et al33 (USS)*
Frediani et al45 (USS)
Falsetti et al44 (USS)
Dasgupta et al15 (USS)
0.66 (0.36 to 0.87)0.89 (0.66 to 0.97)6.2 (1.2 to 32)0.38 (0.15 to 0.97)
Subacromial bursitis on both sides: comparator RADasgupta et al15 (USS)0.32 (0.24 to 0.41)0.78 (0.64 to 0.88)1.5 (0.8 to 2.7)0.87 (0.64 to 0.88)
Ruta et al39 (USS)0.37 (0.22 to 0.55)0.97 (0.83 to 0.99)11 (1.5 to 80)0.66 (0.83 to 0.99)
Iliopsoas bursitisCantini et al34 (MRI)0.50 (0.30 to 0.70)0.80 (0.50 to 0.94)2.5 (0.67 to 9.3)0.63 (0.37 to 1.1)
Cantini et al34 (USS)0.30 (0.15 to 0.50)0.90 (0.77 to 0.96)3.0 (0.95 to 9.4)0.78 (0.57 to 1.1)
Iliopectineal (iliopsoas) bursitis, comparator RATakahashi et al240.59 (0.41 to 0.75)0.90 (0.60 to 0.98)5.9 (0.90 to 39)0.45 (0.28 to 0.75)
Ischiogluteal bursitisCantini et al34 (MRI)0.25 (0.11 to 0.47)0.90 (0.60 to 0.98)2.5 (0.34 to 19)0.83 (0.60 to 1.2)
Yamashita et al35 (PET/CT)0.86 (0.60 to 0.96)0.76 (0.53 to 0.90)3.6 (1.5 to 8.8)0.19 (0.05 to 0.69)
Cantini et al34 (USS)0.20 (0.081 to 0.42)0.95 (0.84 to 0.99)4.0 (0.80 to 20)0.84 (0.70 to 1.1)
Trochanteric bursitis on at least one sideCantini et al34 (USS)0.98 (0.81 to 1.00)0.70 (0.54 to 0.81)3.2 (2.0 to 5.1)0.03 (0.002 to 0.53)
Cantini et al34 (MRI)0.98 (0.81 to 1.00)0.78 (0.48 to 0.93)4.3 (1.4 to 13)0.031 (0.002 to 0.49)
Dasgupta et al15 (USS)0.21 (0.15 to 0.30)0.91 (0.84 to 0.95)2.3 (1.2 to 4.5)0.87 (0.78 to 0.97)
Yamashita et al35 (PET/CT)0.71 (0.45 to 0.88)0.88 (0.66 to 0.97)6.1 (1.6 to 23)0.32 (0.14 to 0.76)
Hand extracapsular: comparator RAMarzo-Ortega et al13 (MRI)0.80 (0.49 to 0.94)0.80 (0.49 to 0.94)4.0 (1.1 to 14)0.25 (0.07 to 0.90)
Shoulder extracapsular: comparator RAMcGonagle et al12 (MRI)0.64 (0.39 to 0.84)0.86 (0.60 to 0.96)4.5 (1.2 to 17)0.42 (0.2 to 0.87)
Long head biceps tenosynovitis on at least one sideCantini et al33 (USS)0.81 (0.70 to 0.89)0.47 (0.38 to 0.57)1.5 (1.2 to 1.9)0.41 (0.23 to 0.72)
Dasgupta et al15 (USS)0.66 (0.57 to 0.74)0.54 (0.46 to 0.61)1.4 (1.2 to 1.8)0.63 (0.47 to 0.85)
Frediani et al45 (USS)0.68 (0.54 to 0.79)0.59 (0.49 to 0.68)1.7 (1.2 to 2.2)0.54 (0.35 to 0.84)
Long head biceps tenosynovitis on at least one side: comparator RACoari et al38 (USS)0.16 (0.07 to 0.32)0.48 (0.38 to 0.58)0.30 (0.13 to 0.69)1.8 (1.4 to 2.3)
Dasgupta et al15 (USS)0.66 (0.57 to 0.74)0.44 (0.31 to 0.59)1.2 (0.89 to 1.6)0.76 (0.51 to 1.2)
Ruta et al39 (USS)0.63 (0.46 to 0.78)0.57 (0.39 to 0.73)1.5 (0.89 to 2.4)0.65 (0.37 to 1.1)
Lange et al46 (USS)0.14 (0.05 to 0.33)0.59 (0.41 to 0.74)0.33 (0.11 to 1.0)1.5 (1.0 to 2.1)
Coari et al38 (USS)
Dasgupta et al15 (USS)
Ruta et al39 (USS)
Lange et al46 (USS)
0.37 (0.15 to 0.66)0.50 (0.43 to 0.57)0.74 (0.35 to 1.6)1.3 (0.80 to 2.0)
Salvarani et al48 (MRI)0.47 (0.25 to 0.70)0.67 (0.35 to 0.88)1.4 (0.48 to 4.1)0.80 (0.41 to 1.6)
Long head biceps tenosynovitis on at least one side: comparator painful shoulder conditionsCoari et al38 (USS)0.16 (0.069 to 0.32)0.45 (0.37 to 0.54)0.28 (0.13 to 0.65)1.9 (1.5 to 2.4)
Dasgupta et al15 (USS)0.66 (0.57 to 0.74)0.60 (0.45 to 0.72)1.6 (1.1 to 2.4)0.57 (0.40 to 0.80)
Ruta et al39 (USS)0.47 (0.35 to 0.59)0.80 (0.68 to 0.88)2.3 (1.3 to 4.1)0.67 (0.51 to 0.87)
Long head biceps tenosynovitis on both sidesCantini et al33 (USS)0.60 (0.47 to 0.72)0.96 (0.90 to 0.98)15 (5.8 to 41)0.42 (0.30 to 0.58)
Frediani et al45 (USS)0.38 (0.26 to 0.52)0.68 (0.58 to 0.76)1.2 (0.75 to 1.9)0.91 (0.71 to 1.2)
Falsetti et al44 (USS)0.62 (0.44 to 0.77)0.66 (0.48 to 0.80)1.8 (1.0 to 3.2)0.58 (0.34 to 0.98)
Dasgupta et al15 (USS)0.37 (0.29 to 0.46)0.73 (0.66 to 0.80)1.4 (0.98 to 2.0)0.86 (0.72 to 1.0)
Cantini et al33 (USS)
Frediani et al45 (USS)
Falsetti et al44 (USS)*
Dasgupta et al15 (USS)
0.47 (0.35 to 0.58)0.80 (0.61 to 0.91)2.4 (0.93 to 6.0)0.67 (0.46 to 0.95)
Long head biceps tenosynovitis on both sides: comparator RADasgupta et al15 (USS)0.37 (0.29 to 0.46)0.62 (0.48 to 0.75)0.99 (0.63 to 1.5)1.0 (0.77 to 1.3)
Ruta et al39 (USS)0.30 (0.17 to 0.48)0.98 (0.86 to 1.00)19 (1.2 to 310)0.71 (0.56 to 0.90)
Tenosynovitis of hand extensor tendonsCimmino et al40 (MRI)0.67 (0.42 to 0.85)0.69 (0.42 to 0.87)2.2 (0.89 to 5.3)0.48 (0.22 to 1.1)
Glenohumeral synovitis on at least one sideCantini et al33 (USS)0.77 (0.65 to 0.86)0.42 (0.33 to 0.51)1.3 (1.1 to 1.6)0.54 (0.32 to 0.92)
Frediani et al45 (USS)0.66 (0.52 to 0.78)0.65 (0.55 to 0.73)1.9 (1.4 to 2.6)0.52 (0.35 to 0.79)
Falsetti et al44 (USS)0.66 (0.47 to 0.80)0.47 (0.31 to 0.64)1.2 (0.81 to 1.9)0.74 (0.40 to 1.4)
Dasgupta et al15 (USS)0.39 (0.30 to 0.48)0.71 (0.64 to 0.78)1.3 (0.96 to 1.9)0.86 (0.72 to 1.0)
Cantini et al33 (USS)
Frediani et al45 (USS)
Falsetti et al44 (USS)
Dasgupta et al15 (USS)
0.62 (0.46 to 0.76)0.58 (0.45 to 0.69)1.5 (1.2 to 1.7)0.66 (0.50 to 9.9)
Glenohumeral synovitis on at least one side: comparator RALange et al46 (USS)0.41 (0.23 to 0.61)0.34 (0.20 to 0.53)0.62 (0.35 to 1.1)1.7 (0.93 to 3.2)
Coari et al38 (USS)0.66 (0.48 to 0.80)0.52 (0.42 to 0.62)1.4 (0.99 to 1.9)0.66 (0.39 to 1.1)
Ruta et al39 (USS)0.20 (0.10 to 0.37)0.57 (0.39 to 0.73)0.46 (0.20 o 1.1)1.4 (0.99 to 2.0)
Dasgupta et al15 (USS)0.39 (0.30 to 0.48)0.63 (0.49 to 0.75)1.1 (0.67 to 1.6)0.97 (0.75 to 1.3)
Lange et al46 (USS)†
Coari et al38 (USS)†
Ruta et al39 (USS)
Dasgupta et al15 (USS)
0.41 (0.26 to 0.58)0.53 (0.45 to 0.62)0.88 (0.58 to 1.3)1.1 (0.82 to 1.5)
Salvarani et al48 (MRI)0.77 (0.50 to 0.92)0.44 (0.19 to 0.73)1.4 (0.72 to 2.7)0.52 (0.15 to 1.8)
Glenohumeral synovitis on at least one side: comparator painful shoulder conditionsCoari et al38 (USS)0.66 (0.48 to 080)0.77 (0.69 to 0.84)2.9 (1.9 to 4.3)0.45 (0.27 to 0.73)
Dasgupta et al15 (USS)0.39 (0.30 to 0.48)0.76 (0.62 to 0.86)1.6 (0.92 to 2.8)0.81 (0.65 to 1.0)
Ruta et al39 (USS)0.12 (0.058 to 0.22)0.93 (0.84 to 0.97)1.8 (0.54 to 5.7)0.95 (0.84 to 1.06)
Glenohumeral synovitis on both sidesDasgupta et al150.26 (0.19 to 0.35)0.83 (0.76 to 0.88)1.5 (0.97 to 2.4)0.89 (0.78 to 1.0)
Falsetti et al440.48 (0.31 to 0.66)0.66 (0.48 to 0.80)1.4 (0.76 to 2.6)0.79 (0.51 to 1.2)
Frediani et al450.52 (0.39 to 0.65)0.78 (0.69 to 0.85)2.4 (1.50 to 3.7)0.62 (0.45 to 0.84)
Glenohumeral synovitis on both sides: comparator RADasgupta et al150.26 (0.19 to 0.35)0.70 (0.55 to 0.81)0.86 (0.50 to 1.5)1.1 (0.85 to 1.3)
Ruta et al390.03 (0.059 to 0.17)0.90 (0.74 to 0.97)0.33 (0.037 to 3.0)1.1 (0.94 to 1.2)
Hip synovitis on at least one sideCantini et al34 (USS)0.45 (0.25 to 0.66)0.55 (0.40 to 0.69)1.0 (0.55 to 1.8)1.0 (0.62 to 1.6)
Frediani et al45 (USS)0.40 (0.28 to 0.54)0.81 (0.72 to 0.87)2.1 (1.2 to 3.6)0.74 (0.58 to 0.95)
Falsetti et al44 (USS)0.24 (0.12 to 0.42)0.88 (0.72 to 0.95)1.9 (0.63 to 5.9)0.87 (0.68 to 1.1)
Dasgupta et al15 (USS)0.26 (0.19 to 0.36)0.81 (0.73 to 0.87)1.4 (0.87 to 2.3)0.90 (0.78 to 1.0)
Cantini et al34 (USS)
Frediani et al45 (USS)
Falsetti et al44 (USS)
Dasgupta et al15 (USS)
0.33 (0.24 to 0.43)0.78 (0.66 to 0.87)1.5 (1.0 to 2.2)0.86 (0.76 to 0.97)
Cantini et al34 (MRI)0.85 (0.64 to 0.95)0.50 (0.24 to 0.76)1.7 (0.89 to 3.2)0.30 (0.089 to 1.0)
Yamashita et al35 (PET/CT)0.86 (0.60 to 0.96)0.65 (0.41 to 0.83)2.4 (1.2 to 4.8)0.22 (0.058 to 0.84)
Hip synovitis on both sidesDasgupta et al15 (USS)0.18 (0.12 to 0.26)0.92 (0.85 to 0.95)2.1 (1.0 to 4.3)0.90 (0.81 to 1.0)
Frediani et al45 (USS)0.32 (0.21 to 0.46)0.83 (0.75 to 0.89)1.88 (1.0 to 3.4)0.82 (0.66 to 1.0)
Shoulder region uptakeYamashita et al35 (PET/CT)0.86 (0.60 to 0.96)0.29 (0.13 to 0.53)1.2 (0.84 to 1.8)0.49 (0.11 to 2.1)
Bilateral shoulder region inflammationDasgupta et al15 (USS)0.59 (0.50 to 0.68)0.57 (0.49 to 0.65)1.4 (1.1 to 1.7)0.71 (0.55 to 0.92)
Macchioni et al23 (USS)0.45 (0.39 to 0.51)0.60 (0.47 to 0.72)1.1 (0.79 to 1.6)0.91 (0.71 to 1.2)
Bilateral shoulder region inflammation: comparator painful shoulder conditionsDasgupta et al15 (USS)0.59 (0.50 to 0.68)0.74 (0.61 to 0.85)2.3 (1.4 to 3.9)0.55 (0.42 to 0.72)
Bilateral shoulder region inflammation: comparator RADasgupta et al15 (USS)0.59 (0.50 to 0.68)0.35 (0.23 to 0.49)0.91 (0.70 to 1.2)1.2 (0.75 to 1.8)
Macchioni 2013 (USS0.56 (0.49 to 0.63)0.74 (0.60 to 0.85)2.2 (1.3 to 3.7)0.60 (0.47 to 0.76)
Hip region inflammation: comparator RADasgupta et al15 (USS)0.38 (0.30 to 0.47)0.70 (0.55 to 0.81)1.3 (0.77 to 2.1)0.89 (0.70 to 1.1)
Hip region inflammation: comparator painful shoulder conditionsDasgupta et al15 (USS)0.38 (0.30 to 0.47)0.83 (0.70 to 0.91)2.3 (1.2 to 4.4)0.74 (0.61 to 0.90)
One shoulder and one hip region inflammationDasgupta et al15 (USS)0.33 (0.26 to 0.42)0.84 (0.77 to 0.89)2.1 (1.3 to 3.2)0.80 (0.69 to 0.92)
Macchioni et al23 (USS)0.34 (0.27 to 0.41)0.77 (0.68 to 0.85)1.5 (0.97 to 2.3)0.86 (0.74 to 1.0)
  • Note these are reported to 2 significant figures but note CIs are often wide. Sensitivity, specificity, positive likelihood ratio and negative likelihood ratio are given for individual tests or, where possible, a summary value is calculated by meta-analysis. Sensitivity and specificity are given to two decimal places. Likelihood ratios are given to two significant figures unless <0.1 or >10.

  • *Outlier by visual inspection of HsROC.

  • †Influential outlier (Cooks’ distance >3). “Shoulder region inflammation”, “hip region inflammation” are defined as per ACR/EULAR provisional classification criteria for PMR.15

  • ACR, American College of Rheumatology; EULAR, the European League Against Rheumatism; HsROC, Hierarchial Summary Receiver-Operator Characteristic Curve; PMR, polymyalgia rheumatica.